COO — Cooper Companies Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Cooper Companies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2020 October 31st	2021 October 31st	2022 October 31st	2023 October 31st	2024 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,431	2,923	3,308	3,593	3,895
Cost of Revenue
Gross Profit	1,535	1,956	2,166	2,358	2,596
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,119	2,417	2,801	3,060	3,190
Operating Profit	312	506	508	533	706
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	267	492	475	413	582
Provision for Income Taxes
Net Income After Taxes	238	2,945	386	294	392
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	238	2,945	386	294	392
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	238	2,945	386	294	392
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.32	14.8	2.08	1.64	2.17
Dividends per Share